Keywords: UK, USA, NICE, Evaluation,

US regulators value the work of the UK’s NICE

Article | 11 December 2009

Speaking at a recent conference of the UK’s National Institute for Health and Clinical Excellence, Steve Pearson, president of the Institute for Clinical and Economic Review at Harvard, USA, said he believes that the NICE has a reputation as a “wonderful” resource for evidence. Adding to this view was Sean Tunis, Director of the Center for Medical Technology in Baltimore, who said that its processes and structures are being used as a model in US health care.

In a session, called International perspectives on innovation and value, Mr Pearson identified two options for judging innovation. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in